Abiopharma

News list

Director Hoffman Michael B 🟢 acquired 15.0K shares of Annovis Bio, Inc. (ANVS) at $2.30 Transaction Date: Aug 29, 2025 | Filing ID: 087077

Full text

News bot Sept. 3, 2025, 8:42 p.m.
🔍 Hoffman Michael B (Director)

Company: Annovis Bio, Inc. (ANVS)

Report Date: 2025-08-29
Transaction Summary:
- Total transactions: 4
- Derivative instruments: 0
- Holdings reported: 1
- Total shares acquired: 15,000
- Total shares held: 223,357
Detailed Transactions and Holdings:
- Acquired 5,000 shares of Common Stock at $2.28 per share (Direct)
  Date: 2025-08-29 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,469,929.00 | transaction_form_type: 4
- Acquired 5,000 shares of Common Stock at $2.29 per share (Direct)
  Date: 2025-08-29 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,474,929.00 | transaction_form_type: 4
- Acquired 5,000 shares of Common Stock at $2.3 per share (Direct)
  Date: 2025-08-29 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,479,929.00 | transaction_form_type: 4
- Holds 0 shares of Common Stock (Direct)
  Date: 2025-08-29 | Code: H | nature_of_ownership: The 2018 Jane and Michael Hoffman Descendants Trust | shares_owned_after: 223,357.00 | Footnotes: F1
Footnotes:
- F1: The shares are held in a family trust formed by the reporting person and the reporting person has voting and investment power over such shares.